`
`Lucentis PFS
`
`TRD Subteam Meeting Minutes
`Business Use Only
`
`Meeting Date: October 11 , 2011
`Meeting minutes: October 17, 2011
`Author:
`
`Team Members:(✓ = Present)
`
`Extended team members
`
`Topic/Situation
`
`Discus.sion & Achievement
`
`I
`
`I
`
`I
`
`TRD subteam meeting minutes 111 02011.docx
`
`1 of 3
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2066.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Topic/Situation
`
`Update on progress
`Expected outcome: for information
`
`Actions
`What
`
`Who
`
`Actions
`When
`
`Topic/Situation
`
`Update team on latest findings
`Expected outcome: agree on next steps
`
`Discussion & Achievement
`
`I
`I
`I
`
`What
`Update presentation when new results
`become available
`Update ■
`
`Who --
`
`I Top;c/Sttuatroo
`Update team
`TRD subteam meeting minutes 111 02011.docx
`
`2 of3
`
`Le~d:
`I Pre-read
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2066.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Expected outcome: for information
`
`Discussion & Achievemt}nt
`
`I
`I
`I
`I
`I
`
`D.istribution of minutes:
`TRD Subteam members & extended members
`
`Actions
`
`When -
`
`TRD subteam meeting minutes 111 02011.docx
`
`3of 3
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2066.003
`Regeneron v. Novartis, IPR2021-00816
`
`